Evidence map›Paper›PMID 36704497›Full record

ArticleInternational journal of health sciences

RSAD2: An exclusive target protein for Zika virus comparative modeling, characterization, energy minimization and stabilization.

Pranaya Thara Rangisetty, Asrita Kilaparthi, Sreevidya Akula, Mahima Bhardwaj, Sachidanand Singh

Open access · greenAbstract read
In one paragraph

Article in International journal of health sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Pranaya Thara RangisettyDepartment of Biotechnology, Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India.
Asrita KilaparthiDepartment of Biotechnology, Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India.
Sreevidya AkulaDepartment of Biotechnology, Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India.
Mahima BhardwajDepartment of Biotechnology, Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India.
Sachidanand SinghDepartment of Biotechnology, Sankalchand Patel University, Visnagar, Gujarat, India.
Vignan's Foundation for Science, Technology & Research · INSankalchand Patel University

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The major purpose of the present study was to predict the structure of Radical s-adenosyl-L-methionine Domain 2 (RSAD2), the most targeted protein of the Zika virus using comparative modeling, to validate the models that were generated and molecular dynamics (MD) simulations were performed. Methods: The secondary structure of RSAD2 was estimated using the Garnier-Osguthorpe-Robson, Self-Optimized Prediction method with Alignment, and Position-Specific Iterative-Blast based secondary structure prediction algorithms. The best of them were preferred based on their DOPE score, then three-dimensional structure identification using SWISS-MODEL and the Protein Homology/Analogy Recognition Engine (Phyre2) server. SAVES 6.0 was used to validate the models, and the preferred model was then energetically stabilized. The model with least energy minimization was used for MD simulations using iMODS. Results: The model predicted using SWISS-MODEL was determined as the best among the predicted models. In the Ramachandran plot, there were 238 residues (90.8%) in favored regions, 23 residues (8.8%) in allowed regions, and 1 residue (0.4%) in generously allowed regions. Energy minimization was calculated using Swiss PDB viewer, reporting the SWISS-MODEL with the lowest energy (E = -18439.475 KJ/mol) and it represented a stable structure conformation at three-dimensional level when analyzed by MD simulations. Conclusion: A large amount of sequence and structural data is now available, for tertiary protein structure prediction, hence implying a computational approach in all the aspects becomes an opportunistic strategy. The best three-dimensional structure of RSAD2 was built and was confirmed with energy minimization, secondary structure validation and torsional angles stabilization. This modeled protein is predicted to play a role in the development of drugs against Zika virus infection.

Indexed as

Comparative modelingenergy minimizationmolecular dynamicsprotein homology/analogy recognition enginesaves 6.0SWISS-MODEL

Identifiers

PMID36704497
PMCPMC9832909
OpenAlexW4318263509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.